If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
BMI View: Gabon's small pharmaceutical market will continue to act as a
deterrent to any local investments by multinational drugmakers. Opportunities
will be largely focused within the generic drug market, yet over the long term,
as the national health insurance scheme gains momentum, this will provide
greater momentum for pharmaceutical expenditure. The Gabonese government will
struggle to increase funding for healthcare to the 15% target set at the Abuja
declaration, and the country will continue to rely on aid funding from external
Headline Expenditure Projections
-Pharmaceuticals: XAF48.1bn (USD81mn) in 2015 to XAF49.9bn (USD81mn) in 2016;
+3.7% in local currency and 0.0% in US dollar terms. Forecast unchanged from
-Healthcare: XAF310.5bn (USD524mn) in 2015 to XAF329.05bn (USD537mn) in 2016;
+6.1% in local currency and +2.4% in US dollar terms. Forecast revised upwards